6533b7dafe1ef96bd126ebd3

RESEARCH PRODUCT

Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question.

Warren StroberMarkus F. NeurathIvan J. FussMonica BoirivantSusetta FinottoPeter R. Galle

subject

T-LymphocytesImmunologyApoptosisInflammatory bowel diseaseImmunology and AllergyMedicineEffective treatmentAnimalsHumansColitisIntestinal MucosaReceptorImmunity MucosalT-cell apoptosisbiologyCell Deathbusiness.industryInflammatory Bowel Diseasesmedicine.diseaseInflammatory Bowel Diseasesdigestive system diseasesApoptosisImmunologybiology.proteinAntibodybusiness

description

T-cell resistance against apoptosis contributes to inappropriate T-cell accumulation and the perpetuation of chronic mucosal inflammation in inflammatory bowel diseases (IBDs). Anti-interleukin-12 (IL-12) and anti-IL-6 receptor antibodies suppress colitis activity by the induction of T-cell apoptosis. These findings have important implications for the design of effective treatment regimens in IBD.

10.1016/s1471-4906(00)01798-1https://pubmed.ncbi.nlm.nih.gov/11286687